Trinity Biotech plc TRIB
6.80 USD +0.54 +8.55%
At close · Nov 2
6.70 -0.09 -1.40%
After hours · Nov 2, 4:00 PM ET
- YTD
- -71.33%
- 1 year
- -77.35%
- Open
- 6.27
- Prev close
- 6.26
- Mkt cap
- 5.53M
- Vol
- 19.88K
- Avg vol
- 19.24K
- EPS
- -60.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.27
- High
- 6.85
- Forward P/E
- -0.87
- Beta
- 1.13
- Short ratio
- 0.43
- Inst. own
- 23.96%
- Dividend
- 0.00
- Ex-div date
- Jun 4, 2015
- 50-d avg
- 1.39
- 200-d avg
- 1.90
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for TRIB has not been loaded yet. Try again in a moment.
Altman Z-Score
-2.18 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -0.4×
P/S 0.3×
P/B -0.2×
P/FCF -1.2×
EV/EBITDA -6.9×
EV/Sales 3.4×
FCF Yield -82.7%
Gross Margin 38.6%
Operating Margin -26.1%
Net Margin -85.4%
ROE 51.9%
ROIC -15.3%
ROA -35.5%
Revenue -28.9%
Operating Income 46.1%
EPS (diluted) -13.3%
Free Cash Flow 14.8%
Current Ratio 0.3×
Quick Ratio 0.1×
Debt / Equity -1.9×
Net Debt / EBITDA -6.2×
Interest Coverage -0.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31